We are glad you want to connect with us! Fill out the form and we'll contact you to set up a call or meeting.
Fill out the form and get news about our journey in Mevia's monthly newsletter.
Mevia provides a customised and reliable end-to-end solution to ensure medical adherence, safe data management and patient support in clinical trials.
Collect adherence data with Mepill or Medose. Follow the data in Mevia’s dashboard and app in real-time.
Collect real-time adherence data with Mepill or Medose. Cellular devices that connect to medicine packages and automatically let you know when a dose is taken. Choose between Mepill, for single-pill blisters and Medose, for multiple pill dose-dispenser.
View the collected real-time adherence data in our digital dashboard. It allows administrative users to follow-up on adherence behaviours and know when extra counselling is needed. Extract customised PDF:s for accessible material to share.
Provide customised treatment support and collect the health data you need with our easy-to-use application or SMS to Web-set up. The doses are automatically updated in the application when taken by Mepill or Medose.
Mevia is a trusted partner to Merck in a global multi-centre clinical study where they support patient adherence and safe data management
Mevia's collaborative and responsive approach enables us to improve products and services for our customers and their patients
A sustainable option for smart packaging with no single-use electronics that guarantees reliable data collection through a cellular connection.
Increasing the effectiveness of adherence interventions may have a far greater impact on the health of the population than any improvement in specific medical treatments.
.png)
A 1% improvement in adherence gives an average cost saving of 335 700 $ US dollar in clinical trial phase III.
Mevia is providing patient support in multi-centre clinical studies with a global reach. We ensure patient adherence and safe data management as a partner to the pharmaceutical industry, CRO’s and CMO's.
.png)
Use patented technology to accurately register every dose taken
Follow adherence behaviours in real-time
Data to maintain statistical power with fewer participants
Increase well-being and patient safety
Provide support to increase adherence to treatment
Material to engage and discuss around adherence behaviours
Save time, money and paper work
Increase traceability and easily manage your data
Data in real-time and extracted customisable PDFs for actionable insights
In a home care setting, Mevia's solutions were used on 21 residents between the ages of 75 and 90. During the 3-month study, medical deviation decreased from 60% to 14% compared to the same period the year before.
Fifteen subjects over 80 years of age used Mevia's solutions with placebo medication in multi-dose packages for 4 weeks. With the support of the application, the adherence was 87%.
Download study
Our solutions use electronic monitoring to measure when a pill is taken out from the package. When taken out from the package, studies confirm that 97% also consumes the pill.
Our solutions use electronic monitoring to measure when a pill is taken out from the package. When taken out from the package, studies confirm that 97% also consumes the pill.